StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note published on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Athersys Price Performance
Athersys has a one year low of $0.01 and a one year high of $1.99. The stock has a market capitalization of $833,000.00, a price-to-earnings ratio of 0.00 and a beta of -0.90.
Athersys Company Profile
Featured Articles
- Five stocks we like better than Athersys
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- What Investors Need to Know to Beat the Market
- Are Tariffs Threatening Disney’s Comeback Story?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
